Scrip
Dendreon completes US filing for therapeutic cancer vaccine Provenge
03 November 2009
Malini Guha
Dendreon has completed its US filing for Provenge (sipuleucel-T) for advanced prostate cancer, putting the novel therapy on track for a much-anticipated FDA approval that would make it the first US-approved therapeutic cancer vaccine.
The amended BLA for the US biotech's lead product includes...
Please Login to read the full article.
03 November 2009
Malini Guha
The amended BLA for the US biotech's lead product includes...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
